Kyle D Reichl

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Systematic Review

Top Venues

Expert opinion on therapeutic patents

Journal of the American Chemical Society

This page only lists publications with an associated author ORCID identifier.

Publications

Kyle D Reichl, Esther C Y Lee, Ariamala Gopalsamy
Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors - a review of patent literature from 2019-30 June 2023. Expert opinion on therapeutic patents 34 (3) (2024)
Kyle D Reichl, Esther C Y Lee, Ariamala Gopalsamy
Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors - a review of patent literature from 2019-30 June 2023. Expert opinion on therapeutic patents (2024)
Kyle D Reichl, Esther C Y Lee, Ariamala Gopalsamy
Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors - a review of patent literature from 2019-30 June 2023. Expert opinion on therapeutic patents 34 (3) (2024)
Esther C Y Lee, Kyle D Reichl, Ariamala Gopalsamy
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors - a review of patent literature from 2019-June 2023. Expert opinion on therapeutic patents (2024)
Kyle D Reichl, Esther C Y Lee, Ariamala Gopalsamy
Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors - a review of patent literature from 2019-30 June 2023. Expert opinion on therapeutic patents 34 (3) (2024)
Esther C Y Lee, Kyle D Reichl, Ariamala Gopalsamy
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors - a review of patent literature from 2019-June 2023. Expert opinion on therapeutic patents 34 (4) (2024)
Esther C Y Lee, Kyle D Reichl, Ariamala Gopalsamy
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors - a review of patent literature from 2019-June 2023. Expert opinion on therapeutic patents (2024)
Esther C Y Lee, Kyle D Reichl, Ariamala Gopalsamy
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors - a review of patent literature from 2019-June 2023. Expert opinion on therapeutic patents 34 (4) (2024)
Xiaowei Wu, Takayuki Iwata, Adam Scharf, Tian Qin, Kyle D Reichl, John A Porco
Asymmetric Synthesis of Gonytolide A: Strategic Use of an Aryl Halide Blocking Group for Oxidative Coupling. Journal of the American Chemical Society 140 (18) (2018)
Michael J Smith, Kyle D Reichl, Randolph A Escobar, Thomas J Heavey, David F Coker, Scott E Schaus, John A Porco
Asymmetric Synthesis of Griffipavixanthone Employing a Chiral Phosphoric Acid-Catalyzed Cycloaddition. Journal of the American Chemical Society 141 (1) (2018)
Kyle D Reichl, Michael J Smith, Min K Song, Richard P Johnson, John A Porco
Biomimetic Total Synthesis of (±)-Griffipavixanthone via a Cationic Cycloaddition-Cyclization Cascade. Journal of the American Chemical Society 139 (40) (2017)